Gene Express Lung Cancer Diagnostic Demonstrates 96% Accuracy in Study
TOLEDO, OH -- (MARKET WIRE) -- 09/27/07 -- Gene Express, Inc. today announced that its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study presented at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.